Saratov JOURNAL of Medical and Scientific Research
Home

Modern approach to Valsalva retinopathy treatment

Year: 2020, volume 16 Issue: №1 Pages: 268-272
Heading: Ophtalmology Article type: Original article
Authors: Sakhnov S.N., Karagodina P.A., Klokova O.A., Leonova A.A.
Organization: Kuban State Medical University, S. Fyodorov Eye Microsurgery Federal State Institution
Summary:

The purpose of the study was to perform retrospective analysis of laser hyaloid puncture results depending on the period of its performance after the occurrence of Valsalva retinopathy. Material and Methods. Retrospective analysis of the results of laser intervention in 17 patients with Valsalva retinopathy aged 24 to 48 years at the time of the disease from 1 to 30 days (12.3±0.8) was performed. To carry out the laser hyaloid puncture, an Aura laser unit (LUMENEIS, USA) with a wavelength of 1064 nm was used. Results. All the procedures were performed without complications. Laser hyaloid puncture was carried out on 6 eyes (35.3%) within 10 days after hemorrhage, on 9 eyes (52.9%) after 11-21 days and on 2 (11.8%) after 23 and 30 days. The average increase in vision acuity 1 hour after surgery comprised 0.38±0.18. One month after the surgery, in patients operated on during the first 7-10 days after the occurrence of preretinal hemorrhage, an average visual acuity (0.93±0.07) was statistically significantly higher (P<0.05) compared with the average visual acuity of patients, who underwent the laser hyaloid puncture after 11-21 days (0.75±0.11) and 22-30 days (0.65±0.21). Conclusion. Laser hyaloid puncture performance in the early period after the occurrence of preretinal hemorrhage is pathogenetically justified and allows to restore the visual functions of patients and their working ability in the shortest period of time.

Keywords: laser hyaloid puncture, preretinal hemorrhage, Valsalva retinopathy

Bibliography:
1. Shadrichev FE. Diabetic Retinopathy (Ophthalmologist View). Diabetes Mellitus 2008; (3): 8-10.
2. Duane TD. Valsalva hemorrhagic retinopathy. Trans Am Ophthalmol Soc 1972; 70: 298-313.
3. Ahmadabadi MN, Karkhaneh R, Mirshahi A, et al. Premacular Hemorrhage in Valsalva Retinopathy: A Study of 21 Cases. Iranian Journal of Ophthalmology 2009; 21 (3): 11-6.
4. Durukan A H, Kerimoglu H, Erdurman C, et al. Long-term results of Nd: YAG laser treatment for premacular subhyaloid haemorrhage owing to Valsalva retinopathy. Eye 2008; 22 (2): 214-8.
5. Khan M T, Saeed M U, Shehzad M S et al. Nd: YAG laser treatment for Valsalva premacular hemorrhages: 6 month follow up: Alternative management options for preretinal premacular hemorrhages in Valsalva retinopathy. Int Ophthalmol 2008; (28): 325-7.
6. Lomukhina EA. The experience of surgical treatment of patients with Valsalva retinopathy. Modern Technologies in Ophthalmology 2019; (1): 127-32.
7. Faulborn J. Behandlung einerdiabetischen premacularen: Blutung mit dem Q-switched Nd: YAG laser. Spektrum Augenheilkd 1988;2:33-5.
8. Imantaeva MB, Stepanova IS, Assylbekova AS, Nurakhunova VA. Valsalva Retinopathy (clinical case). Vitreoretinal Pathology and Diseases of the Optic Nerve 2018; (2): 103-7.
9. Kwok АК, Lai TY, Chan NR. Epiretinal membrane formation with internal limiting membrane wrinkling after Nd: YAG laser membranotomy in Valsalva retinopathy. Am J Ophthalmol 2003; 136 (4): 763-66.

AttachmentSize
2020_01-2_268-272.pdf1.45 MB
All articles of the authors: Karagodina P.A., Klokova O.A., Leonova A.A., Sakhnov S.N.

No votes yet